However, DPP-IV was reported to act as a tumor suppressor in prostate adenocarcinoma cells, where its transgenic overexpression led to apoptosis, cell cycle arrest, and the inhibition of in vitro cell migration and invasion [72]. Here, DPP4 is linked to neoplasm.